Deutsche Bank
OKUR

Deutsche Bank’s OnKure Therapeutics OKUR Stock Holding History

Deutsche Bank’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Buy
+25,564
New +$110K ﹤0.01% 3440
2022
Q2 		– Sell
-472
Closed -$14K – 4358
2022
Q1 		$14K Sell
472
-56
-11% -$3.13K ﹤0.01% 4093
2021
Q4 		$45K Buy
528
+165
+45% +$12.1K ﹤0.01% 3984
2021
Q3 		$27K Sell
363
-12
-3% -$1.02K ﹤0.01% 4207
2021
Q2 		$35K Buy
+375
New +$41.8K ﹤0.01% 4363

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deutsche Bank's OKUR Position: Q2 2026 in Review

Deutsche Bank opened a new position in OnKure Therapeutics (OKUR) in Q2 2026: 25,564 shares worth $117K. The stake represents ﹤0.01% of the portfolio and ranks #3440 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in OKUR as recently as Q1 2022.

Deutsche Bank first reported a position in OKUR in Q2 2021 and has held it in 5 quarters since. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • Deutsche Bank held 25,564 shares of OnKure Therapeutics worth $117K as of Q2 2026.
  • OnKure Therapeutics was a new Deutsche Bank position in Q2 2026.
  • OnKure Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3440 holding.
  • Deutsche Bank first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 5 quarters since.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.